Substances

European Drug Report 2024: Trends and Developments

Report

The European Drug Report 2024: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report provides a comprehensive set of national...

Dashboard. Prevalence of cannabis use in Europe (updated June 2024)

The Challenge of New Psychoactive Substances – A Technical Update 2024

Report

"The Challenge of New Psychoactive Substances – A Technical Update 2024" is an update of the UNODC publication “The Challenge of New Psychoactive Substances (NPS), 2013”, which focuses on the new psychoactive substances (NPS) encountered on...

K2/Spice: Learning about Synthetic Cannabinoids

15 July 2024

Online

Time: 9AM - 10:15AM Eastern Time

The increasing availability of synthetic cannabinoids warrants a further understanding of this compound, its side effects, tools to use for screening, and how this information is useful in delivering behavioral health services.

Speaker:

Andrew Kurtz, MA, LMFT

The Process of the Implementation of Quality Standards in Drug Prevention in Croatia: A Case Study

Scientific article

15 April 2024

INTRODUCTION: Prevention science and quality standards of drug prevention in the EU and in the world have developed in recent decades. Progress has been made in quality development in Croatia, but the experience of the process of improving...

Implementing Quality Measurement in the Field of Drug Treatment and Harm Reduction: A Case Study in Flanders

Scientific article

31 March 2024

BACKGROUND: Implementing quality measurement is still a challenge in the field of drug treatment and harm reduction. In this case study, we investigate which strategies can be used to enhance the implementation of a policy in which quality...

The ASPIRE Standards: Taking a Step Towards Quality Assurance in Drug Prevention in France – A Case Study

Scientific article

20 February 2024

INTRODUCTION: In the favourable political climate of the mid-2010s, the standards for Assessment & Selection of Prevention programmes Issued from the Review of EDPQS (ASPIRE) were developed to support project planning in drug prevention...

The Implementation of Quality Standards (QS) at Coolmine Therapeutic Community

Scientific article

15 March 2024

BACKGROUND: Coolmine’s implementation of quality standards involves a period of change management, strategic planning, and national policy development. METHODS: A narrative case study focusing on national policy and internal strategic...

Substance Use Disorder Treatment Quality Standards in Lithuania 1992–2022: From Grassroots Initiatives to Nationwide Strategies

Scientific article

27 December 2024

BACKGROUND: The implementation of quality standards in the treatment of substance use disorders in Lithuania is not well documented in the literature. AIMS: To describe the process of the development of quality standards from grassroots...

Relación entre el trastorno de depresión y la adicción a Internet en jóvenes del Aglomerado Gran Buenos Aires.

Scientific article

1 July 2022

The present work seeks to analyse whether there is a relationship between the development of depression disorder and Internet addiction. For its development, the results of the Beck Depression Inventory were evaluated in a group of 60...

Bi-Monthly Webinar: ISSUP Nigeria Knowledge Update Series (22nd Session)

ISSUP Webinar

11 June 2024

ISSUP Nigeria presents the 22nd session of its bi-monthly webinar in the Knowledge Update Series. This webinar will focus on the topic of 'Therapeutic Community as a model in the Management of Substance Use Disorders.'